Optimal Digoxin Concentrations for Patients With Heart Failure

[1]  Harlan M Krumholz,et al.  Association of serum digoxin concentration and outcomes in patients with heart failure. , 2003, JAMA.

[2]  S. Weinstein,et al.  Health and function of patients with untreated idiopathic scoliosis: a 50-year natural history study. , 2003, JAMA.

[3]  S. Czajkowski,et al.  The effect of digoxin on the quality of life in patients with heart failure. , 2003, Journal of cardiac failure.

[4]  V. Deviren,et al.  Predictors of Flexibility and Pain Patterns in Thoracolumbar and Lumbar Idiopathic Scoliosis , 2002, Spine.

[5]  Harlan M Krumholz,et al.  Sex-based differences in the effect of digoxin for the treatment of heart failure. , 2002, The New England journal of medicine.

[6]  K. Brouwer,et al.  Pharmacokinetic and Pharmacodynamic Implications of P‐glycoprotein Modulation , 2001, Pharmacotherapy.

[7]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[8]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[9]  M. Branthwaite.  Cardiorespiratory consequences of unfused idiopathic scoliosis. , 1986, British journal of diseases of the chest.

[10]  K. Nademanee,et al.  Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications. , 1984, Journal of the American College of Cardiology.

[11]  R. M. Peters.  Diseases of the Chest (4th Ed) , 1981 .

[12]  R. Dickson,et al.  Cotrel traction, exercises, casting in the treatment of idiopathic scoliosis. A pilot study and prospective randomized controlled clinical trial. , 1978, Acta orthopaedica Scandinavica.

[13]  E. Iisalo.  Clinical Pharmacokinetics of Digoxin , 1977, Clinical pharmacokinetics.